Cargando…

Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome

POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) is a rare paraneoplastic syndrome due to a plasma cell disorder. Diagnosis requires peripheral neuropathy and a monoclonal plasma cell disorder along with one major and one minor criteria, but cardiac man...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelahad, Mandi, Pearson, Ryan, Mauri, Bryant, Fenton, Kira, Savu, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523341/
https://www.ncbi.nlm.nih.gov/pubmed/34692278
http://dx.doi.org/10.7759/cureus.18046
_version_ 1784585281712685056
author Abdelahad, Mandi
Pearson, Ryan
Mauri, Bryant
Fenton, Kira
Savu, Cristina
author_facet Abdelahad, Mandi
Pearson, Ryan
Mauri, Bryant
Fenton, Kira
Savu, Cristina
author_sort Abdelahad, Mandi
collection PubMed
description POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) is a rare paraneoplastic syndrome due to a plasma cell disorder. Diagnosis requires peripheral neuropathy and a monoclonal plasma cell disorder along with one major and one minor criteria, but cardiac manifestations are uncommon. The pathogenesis of POEMS syndrome is not well understood but it is thought to involve overproduction of proinflammatory cytokines, such as vascular endothelial growth factor (VEGF), interleukin-1 beta (IL-1B), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). POEMS syndrome commonly presents in the fifth to sixth decade of life, mainly in non-Hispanic Caucasian individuals, and affects more men than women (2:1). We report a unique case of a 28-year-old African American female with a history of POEMS syndrome and a new diagnosis of dilated, non-ischemic cardiomyopathy and New York Heart Association (NYHA) class IV, stage D heart failure with an ejection fraction (EF) of 30% as a result of the natural progression of her untreated POEMS syndrome.
format Online
Article
Text
id pubmed-8523341
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-85233412021-10-22 Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome Abdelahad, Mandi Pearson, Ryan Mauri, Bryant Fenton, Kira Savu, Cristina Cureus Cardiology POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) is a rare paraneoplastic syndrome due to a plasma cell disorder. Diagnosis requires peripheral neuropathy and a monoclonal plasma cell disorder along with one major and one minor criteria, but cardiac manifestations are uncommon. The pathogenesis of POEMS syndrome is not well understood but it is thought to involve overproduction of proinflammatory cytokines, such as vascular endothelial growth factor (VEGF), interleukin-1 beta (IL-1B), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). POEMS syndrome commonly presents in the fifth to sixth decade of life, mainly in non-Hispanic Caucasian individuals, and affects more men than women (2:1). We report a unique case of a 28-year-old African American female with a history of POEMS syndrome and a new diagnosis of dilated, non-ischemic cardiomyopathy and New York Heart Association (NYHA) class IV, stage D heart failure with an ejection fraction (EF) of 30% as a result of the natural progression of her untreated POEMS syndrome. Cureus 2021-09-17 /pmc/articles/PMC8523341/ /pubmed/34692278 http://dx.doi.org/10.7759/cureus.18046 Text en Copyright © 2021, Abdelahad et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Abdelahad, Mandi
Pearson, Ryan
Mauri, Bryant
Fenton, Kira
Savu, Cristina
Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
title Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
title_full Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
title_fullStr Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
title_full_unstemmed Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
title_short Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
title_sort heart failure with cardiogenic shock as a manifestation of untreated poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) syndrome
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523341/
https://www.ncbi.nlm.nih.gov/pubmed/34692278
http://dx.doi.org/10.7759/cureus.18046
work_keys_str_mv AT abdelahadmandi heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome
AT pearsonryan heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome
AT mauribryant heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome
AT fentonkira heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome
AT savucristina heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome